Lupin Limited has informed the Exchange regarding a press release dated January 06, 2021, titled "Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.".
Lupin Limited has informed the Exchange regarding a press release dated January 06, 2021, titled "Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.".